| Primary |
| Gout |
17.2% |
| Chronic Lymphocytic Leukaemia |
10.3% |
| Multiple Myeloma |
10.3% |
| Pancreatic Carcinoma |
10.3% |
| Product Used For Unknown Indication |
10.3% |
| Tumour Lysis Syndrome |
10.3% |
| Antipsychotic Drug Level Increased |
6.9% |
| Drug Use For Unknown Indication |
6.9% |
| Blood Uric Acid Increased |
3.4% |
| Chemotherapy |
3.4% |
| Embolism |
3.4% |
| Myelodysplastic Syndrome |
3.4% |
| Sleep Disorder |
3.4% |
|
| Medication Error |
10.0% |
| Toxic Epidermal Necrolysis |
10.0% |
| Blister |
5.0% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
5.0% |
| Joint Effusion |
5.0% |
| Pain Of Skin |
5.0% |
| Product Name Confusion |
5.0% |
| Product Solubility Abnormal |
5.0% |
| Pruritus Generalised |
5.0% |
| Renal Failure Acute |
5.0% |
| Serum Sickness |
5.0% |
| Speech Disorder |
5.0% |
| Swelling |
5.0% |
| Swelling Face |
5.0% |
| Thrombocytopenia |
5.0% |
| Weight Decreased |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Wound Infection Staphylococcal |
5.0% |
|
| Secondary |
| Product Used For Unknown Indication |
26.7% |
| Drug Use For Unknown Indication |
19.0% |
| Multiple Myeloma |
15.5% |
| Cardiac Failure Congestive |
5.2% |
| Blood Cholesterol |
3.4% |
| Gout |
3.4% |
| Psoriatic Arthropathy |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Arthritis |
2.6% |
| Dizziness |
2.6% |
| Pain |
2.6% |
| Sleep Disorder |
2.6% |
| Crohn's Disease |
1.7% |
| Depression |
1.7% |
| Hypertension |
1.7% |
| Gout |
0.9% |
| Chemotherapy |
0.9% |
| Dvt Of Legs |
0.9% |
| Embolism |
0.9% |
| Malignant Melanoma |
0.9% |
|
| Systemic Lupus Erythematosus |
15.4% |
| Toxic Epidermal Necrolysis |
15.4% |
| Weight Decreased |
15.4% |
| Cardiac Failure |
11.5% |
| Wound |
11.5% |
| Somnolence |
7.7% |
| Dyspnoea |
3.8% |
| Lymphocyte Count Increased |
3.8% |
| Nausea |
3.8% |
| Pneumonia |
3.8% |
| Skin Discolouration |
3.8% |
| Thrombocytopenia |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.1% |
| Drug Use For Unknown Indication |
22.4% |
| Hypertension |
7.2% |
| Gout |
3.7% |
| Pain |
3.5% |
| Atrial Fibrillation |
3.0% |
| Diffuse Large B-cell Lymphoma |
2.8% |
| Prophylaxis |
2.7% |
| Multiple Myeloma |
2.4% |
| Osteoporosis |
2.3% |
| Nuclear Magnetic Resonance Imaging |
2.2% |
| B-cell Lymphoma |
1.8% |
| Diabetes Mellitus |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Acute Myeloid Leukaemia |
1.6% |
| Cardiac Failure Chronic |
1.5% |
| Crohn's Disease |
1.3% |
| Renal Failure Chronic |
1.3% |
| Blood Cholesterol Increased |
1.2% |
|
| Vomiting |
9.4% |
| Weight Increased |
8.5% |
| White Blood Cell Count Increased |
8.5% |
| Transient Ischaemic Attack |
7.3% |
| Death |
6.4% |
| Weight Decreased |
6.4% |
| Myocardial Infarction |
5.1% |
| Renal Failure |
5.1% |
| Dyspnoea |
4.3% |
| Renal Failure Acute |
4.3% |
| Thrombocytopenia |
4.3% |
| Pneumonia |
3.8% |
| Pyrexia |
3.8% |
| Drug Ineffective |
3.4% |
| Pain |
3.4% |
| Vision Blurred |
3.4% |
| Wheezing |
3.4% |
| Febrile Neutropenia |
3.0% |
| Nausea |
3.0% |
| Renal Impairment |
3.0% |
|
| Interacting |
| Nephrolithiasis |
40.0% |
| Back Pain |
20.0% |
| Blood Pressure |
20.0% |
| Erectile Dysfunction |
20.0% |
|
| Nephrolithiasis |
50.0% |
| Sluggishness |
50.0% |
|
